Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (191-200 of 349) with videos related to

Pageof 35
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|August 3, 2012
Multiple-dose pharmacokinetics of fesoterodine sustained-release in healthy Korean volunteersDongseong Shin, Kwang-Hee Shin, SeungHwan Lee, et al.
Clinical Therapeutics|September 17, 2024
Pharmacokinetics and Pharmacodynamics of a Fixed-Dose Combination of Esomeprazole and Magnesium Hydroxide Compared to the Enteric-Coated EsomeprazoleYoonjin Kim, Sungyeun Bae, Inseung Jeon, et al.
Bone Marrow Transplantation|August 30, 2019
Pharmacokinetics of high-dose carboplatin in children undergoing high-dose chemotherapy and autologous stem cell transplantation with BSA-based dosingChe Ry Hong, Hyoung Jin Kang, Seol Ju Moon, et al.
Clinical and Translational Science|September 30, 2022
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first-in-class, first-in-human studyJoo Young Na, Deok Yong Yoon, Hyounggyoon Yoo, et al.
Drug Metabolism and Pharmacokinetics|May 16, 2019
Quantitative prediction of hepatic CYP3A activity using endogenous markers in healthy subjects after administration of CYP3A inhibitors or inducersJieon Lee, Seo Hyun Yoon, Sojeong Yi, et al.
Clinical Therapeutics|September 4, 2017
Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male SubjectsYun Kim, Anhye Kim, SeungHwan Lee, et al.
Therapeutic Drug Monitoring|July 18, 2024
Coadministration of Voriconazole and Rifabutin Can Increase the Risk of Adverse Drug Reactions in Patients With Multiple InfectionsYoonjin Kim, Sungyeun Bae, Ki Young Huh, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2017
Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjectsYewon Choi, Sang Won Lee, Anhye Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 29, 2017
LBEC0101, A Proposed Etanercept Biosimilar: Pharmacokinetics, Immunogenicity, and Tolerability Profiles Compared with a Reference Biologic Product in Healthy Male SubjectsHeechan Lee, Hyewon Chung, SeungHwan Lee, et al.
Scientific Reports|January 31, 2015
Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathwayKumsun Cho, Jae Yong Chung, Sung Kweon Cho, et al.
Pageof 35

Showing results (191-200 of 349) with videos related to

Sort By:
Pageof 35
International Journal of Clinical Pharmacology and Therapeutics|August 3, 2012
Multiple-dose pharmacokinetics of fesoterodine sustained-release in healthy Korean volunteersDongseong Shin, Kwang-Hee Shin, SeungHwan Lee, et al.
Clinical Therapeutics|September 17, 2024
Pharmacokinetics and Pharmacodynamics of a Fixed-Dose Combination of Esomeprazole and Magnesium Hydroxide Compared to the Enteric-Coated EsomeprazoleYoonjin Kim, Sungyeun Bae, Inseung Jeon, et al.
Bone Marrow Transplantation|August 30, 2019
Pharmacokinetics of high-dose carboplatin in children undergoing high-dose chemotherapy and autologous stem cell transplantation with BSA-based dosingChe Ry Hong, Hyoung Jin Kang, Seol Ju Moon, et al.
Clinical and Translational Science|September 30, 2022
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first-in-class, first-in-human studyJoo Young Na, Deok Yong Yoon, Hyounggyoon Yoo, et al.
Drug Metabolism and Pharmacokinetics|May 16, 2019
Quantitative prediction of hepatic CYP3A activity using endogenous markers in healthy subjects after administration of CYP3A inhibitors or inducersJieon Lee, Seo Hyun Yoon, Sojeong Yi, et al.
Clinical Therapeutics|September 4, 2017
Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male SubjectsYun Kim, Anhye Kim, SeungHwan Lee, et al.
Therapeutic Drug Monitoring|July 18, 2024
Coadministration of Voriconazole and Rifabutin Can Increase the Risk of Adverse Drug Reactions in Patients With Multiple InfectionsYoonjin Kim, Sungyeun Bae, Ki Young Huh, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2017
Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjectsYewon Choi, Sang Won Lee, Anhye Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 29, 2017
LBEC0101, A Proposed Etanercept Biosimilar: Pharmacokinetics, Immunogenicity, and Tolerability Profiles Compared with a Reference Biologic Product in Healthy Male SubjectsHeechan Lee, Hyewon Chung, SeungHwan Lee, et al.
Scientific Reports|January 31, 2015
Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathwayKumsun Cho, Jae Yong Chung, Sung Kweon Cho, et al.
Pageof 35